FDA Announces Semaglutide Shortage Resolved On February 21, 2025, the FDA announced that the shortage of semaglutide has been resolved due to increased manufacturing capacity
And always verify your math before drawing the dose, especially during the transition weeks when you are moving to a new unit measurement for the first time
Counsel patients to report symptoms of thyroid tumors (e.g., a lump in the neck, persistent hoarseness, dysphagia, or dyspnea) to their healthcare provider [see Boxed Warning and Warnings and Precautions (5.1)]
None of these insights are possible without consistent record keeping
Risk of bias assessment To assess the quality of the included RCTs, we used the Cochrane Collaborations risk-of-bias tool (33), which provided an independent assessment of the risk of bias in the main outcomes of each trial
MOUNJARO delays gastric emptying and thereby has the potential to impact the absorption of concomitantly administered oral medications [see Drug Interactions (7.2)]
